Transparency Market Research
Non-Invasive Prenatal Testing (NIPT) Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2014 – 2020
Published Date 13-Nov-2014
104 Page Report
Buy Now
Request Sample
Press Release Non-Invasive Prenatal Testing (NIPT) Market in 2020: Transparency Market Research
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
REPORT DESCRIPTION
Non-Invasive Prenatal Testing (NIPT) Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2014 – 2020 Non-invasive prenatal testing (NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and Turner syndrome (monosomy X), and also for fetal sex determination. Until recently, amniocentesis, chorionic villus sampling (CVS), maternal serum screening and nuchal translucency (NT) scan were the primary diagnostic and screening methods for chromosomal abnormalities. Advent of non-invasive prenatal test is poised to eliminate disadvantages associated with these methods, such as low rate of accuracy with maternal serum screening and NT scan, and risk of miscarriage with invasive amniocentesis and CVS procedures. This report on non-invasive prenatal testing market studies the current market scenario and future potential for non-invasive prenatal tests globally. Browse the Non-Invasive Prenatal Testing (NIPT) Market Research Report at http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html The major non-invasive prenatal tests studied in this report are BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi and VisibiliT. These tests have been extensively analyzed on the basis of factors such as the technology used, cost to patients, reimbursement coverage, accuracy and geographical reach (availability across various countries). The historical market size and forecast for each of these tests in terms of revenue (USD Million) and volume (Number of tests performed) have been given in the report for the period 2012 to 2020. In addition, the compounded annual growth rate (CAGR) of the overall non-invasive prenatal test market and the above tests has also been provided in the report for the forecast period 2014 to 2020, considering 2012 and 2013 as the base years. The report on non-invasive prenatal testing market also provides comparative analysis of major tests for the years 2013 and 2020. Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=374 In this research study, the global market for non-invasive prenatal testing has been geographically segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The non-invasive prenatal testing market size and forecast in terms of revenue (USD Million) and volume (Number of Tests Performed) for each region has been provided for the period 2012 to 2020 along with the CAGR for the forecast period 2014 to 2020. The non-invasive prenatal testing market study also includes qualitative analysis of the competitive scenario in these regions such as major collaboration and partnership, entry of new entrants, new product launch and other macro economic factors. The market overview section of the report on non-invasive prenatal testing market comprises qualitative analysis of the overall non-invasive prenatal testing market. Browse More Medical Devices Related Research Reports at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html considering the factors determining the market dynamics such as drivers, restraints and opportunities along with the Porter’s five force analysis and market attractiveness analysis. The market overview chapter also provides information such as major chromosomal aneuploidies (Down syndrome, Edwards syndrome, Patau syndrome and monosomy X, and their incidence rate, technological
approach for NIPT and major patents issued to players operating in the market and other companies and academic research institutions. The report also includes a section on the competitive landscape of the market, wherein the market share analysis of leading players in the global non-invasive prenatal testing market, in terms of percentage share in 2013 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the noninvasive prenatal testing market and accentuate market shares. The report concludes with the profiles of major players in the NIPT market such as Sequenom, Inc., Ariosa Diagnostics, Natera, Inc., Illumina, Inc. (Verinata Health, Inc.), BGI Diagnostics, LifeCodexx AG, Laboratory Corporation of America Holdings (LabCorp) and Berry Genomics. Each company profile comprises information such as company overview, financial overview, product portfolio, business strategies and recent developments.
TABLE OF CONTENT Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Assumptions 1.3.2 Sources 1.3.2.1 Secondary Research 1.3.2.2 Primary Research 1.3.3 Models
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Non-Invasive Prenatal Testing (NIPT) Market (2013 & 2020) 2.2 Global Non-Invasive Prenatal Testing Market, by Test, 2013 (USD Million) 2.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2013 & 2020 (Value %) 2.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2013 & 2020 (Volume %)
Chapter 3 Global Non-Invasive Prenatal Testing Market Overview 3.1 Introduction 3.2 Major Chromosomal Aneuploidies and their Incidence Rate 3.2.1 Down Syndrome 3.2.2 Edwards Syndrome 3.2.3 Patau Syndrome 3.2.4 Turner Syndrome 3.2.5 Klinefelter Syndrome 3.2.6 Jacobs Syndrome 3.2.7 Triple X Syndrome
Browse the Non-Invasive Prenatal Testing (NIPT) Market Research Report at http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html
3.3 Technological Approach for NIPT 3.4 Patent Landscape 3.4.1 Major Patents issued to Sequenom, Inc. 3.4.2 Major Patents issued to Ariosa Diagnostics, Inc. 3.4.3 Major Patents issued to Natera, Inc. 3.4.4 Major Patents issued to Verinata Health, Inc. (Illumina, Inc.) 3.4.5 Major Patents issued to Cellscape Corporation 3.4.6 Others 3.5 Market Drivers 3.5.1 High incidence rate of babies born with Down syndrome
3.5.2 Globally rising average maternal age 3.5.3 Increasing demand for early and non-invasive fetal testing procedures 3.6 Market Restraints 3.6.1 Regulatory guidelines and ethical hurdles 3.6.2 Limitations of NIPT 3.6.3 Availability of other screening and testing methods 3.7 Market Opportunities 3.7.1 Capitalizing on the potential presented by the emerging market of Europe 3.8 Porter’s Five Force Analysis for the Global Non-Invasive Prenatal testing Market 3.8.1 Bargaining power of suppliers 3.8.2 Bargaining power of buyers 3.8.1 Threat of substitutes 3.8.2 Threat of new entrants 3.8.3 Competitive rivalry 3.9 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography
Browse the Non-Invasive Prenatal Testing (NIPT) Market Research Report at http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html
Chapter 4 Global Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Test 4.1 Overview 4.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 – 2020 (USD Million) 4.1.2 Global Non-Invasive Prenatal Testing Market Volume, by Test, 2012 – 2020 (Number of Tests Performed)
4.1.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2013 & 2020 (Value %) 4.1.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Test, 2013 & 2020 (Volume %) 4.2 BambniTest 4.2.1 Global BambniTest Test Market Revenue, 2012 – 2020 (USD Million) 4.2.2 Global BambniTest Test Market Volume, 2012 – 2020 (Number of Tests Performed) 4.3 Harmony Prenatal Test 4.3.1 Global Harmony Test Market Revenue, 2012 – 2020 (USD Million) 4.3.2 Global Harmony Test Market Volume, 2012 – 2020 (Number of Tests Performed) 4.4 informaSeq Prenatal Test 4.4.1 Global informaSeq Test Market Revenue, 2014 – 2020 (USD Million) 4.4.2 Global informaSeq Test Market Volume, 2014 – 2020 (Number of Tests Performed) 4.5 MaterniT21 PLUS 4.5.1 Global MaterniT21 PLUS Test Market Revenue, 2012 – 2020 (USD Million) 4.5.2 Global MaterniT21 PLUS Test Market Volume, 2012 – 2020 (Number of Tests Performed) 4.6 Noninvasive Fetal Trisomy (NIFTY) Test 4.6.1 Global NIFTY Test Market Revenue, 2012 – 2020 (USD Million) 4.6.2 Global NIFTY Test Market Volume, 2012 – 2020 (Number of Tests Performed) 4.7 Panorama Test 4.7.1 Global Panorama Test Market Revenue, 2012 – 2020 (USD Million) 4.7.2 Global Panorama Test Market Volume, 2012 – 2020 (Number of Tests Performed) 4.8 PrenaTest 4.8.1 Global PrenaTest Test Market Revenue, 2012 – 2020 (USD Million) 4.8.2 Global PrenaTest Test Market Volume, 2012 – 2020 (Number of Tests Performed)
4.9 verifi 4.9.1 Global verifi Test Market Revenue, 2012 – 2020 (USD Million) 4.9.2 Global verifi Test Market Volume, 2012 – 2020 (Number of Tests Performed)
Browse the Non-Invasive Prenatal Testing (NIPT) Market Research Report at http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html
4.10 VisibiliT Test 4.10.1 Global VisibiliT Test Market Revenue, 2014 – 2020 (USD Million) 4.10.2 Global VisibiliT Test Market Volume, 2014 – 2020 (Number of Tests Performed)
Chapter 5 Global Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Geography 5.1 Overview 5.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 - 2020 (USD Million) 5.1.2 Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2012 - 2020 (Number of Tests Performed) 5.2 North America 5.2.1 North America Non-Invasive Prenatal Testing Market Revenue, 2012 - 2020 (USD Million) 5.2.2 North America Non-Invasive Prenatal Testing Market Volume, 2012 - 2020 (Number of Tests Performed) 5.3 Europe 5.3.1 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 - 2020 (USD Million) 5.3.2 Europe Non-Invasive Prenatal Testing Market Volume, 2012 - 2020 (Number of Tests Performed) 5.4 Asia-Pacific
5.4.1 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 - 2020 (USD Million) 5.4.2 Asia-Pacific Non-Invasive Prenatal Testing Market Volume, 2012 - 2020 (Number of Tests Performed) 5.5 Rest of the World (RoW) 5.5.1 RoW Non-Invasive Prenatal Testing Market Revenue, 2012 - 2020 (USD Million) 5.5.2 RoW Non-Invasive Prenatal Testing Market Volume, 2012 - 2020 (Number of Tests Performed)
Chapter 6 Competitive Landscape 6.1 Market Share Analysis, by Key Players, 2013 (%)
Chapter 7 Recommendations 7.1 Focus on improving technology in order to increase the accuracy, reduce the duration of result generation and price 7.2 Focus on forming alliances with diagnostic service providers in Europe and Asia-Pacific countries 7.3 Mergers and acquisitions
Chapter 8 Company Profiles 8.1 Ariosa Diagnostics, Inc. 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Berry Genomics Co., Ltd
8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments
Browse the Non-Invasive Prenatal Testing (NIPT) Market Research Report at http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html
8.3 BGI Diagnostics 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 LabCorp 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.5 Recent Developments 8.5 LifeCodexx AG 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio
8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Natera, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments
Browse the Non-Invasive Prenatal Testing (NIPT) Market Research Report at http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html
8.7 Sequenom, Inc. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Illumina, Inc. 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Recent Developments
About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Blog: http://tmrresearch.wordpress.com/